GMO Beyond China ETF
BCHI
4 hedge funds and large institutions have $1.6M invested in GMO Beyond China ETF in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
20% less funds holding
Funds holding: 5 → 4 (-1)
28.4% less ownership
Funds ownership: 43.05% → 14.65% (-28%)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
52% less capital invested
Capital invested by funds: $3.35M → $1.6M (-$1.74M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$531K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$63.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$26.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$2.14M |
| 2 |
Jane Street
New York
|
-$301K |
| 3 |
HC
Hara Capital
Bellevue,
Washington
|
-$74.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$583 |
BCHI Hedge Fund Activity: Q2 2025 in Review
4 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in GMO Beyond China ETF (BCHI) for Q2 2025, worth a combined $1.6M — down 52% from $3.35M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BCHI and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Lazard Asset Management, opening a new position worth an estimated $531K. The largest seller was Cresset Asset Management, exiting entirely with an estimated $2.14M sold.
- 4 institutional investors held GMO Beyond China ETF (BCHI) as of Q2 2025, down from 5 in Q1 2025.
- Funds reported $1.6M of GMO Beyond China ETF stock for Q2 2025, down 52% quarter-over-quarter.
- 2 funds opened new GMO Beyond China ETF positions in Q2 2025 and 3 closed out, a net change of -1 holder.
- The largest GMO Beyond China ETF buyer in Q2 2025 was Lazard Asset Management, an estimated $531K added.
- The largest GMO Beyond China ETF seller in Q2 2025 was Cresset Asset Management, an estimated $2.14M sold.
Based on aggregated 13F filings for Q2 2025.